No usable source links are available for this idea. Its signal notes and scores need independent verification.
When SME pharma companies (annual revenue 10-50 billion KRW) adopt AI in manufacturing processes, creating validation documents that meet FDA/MFDS CSV (Computer System Validation) and GAMP5 standards costs 30-50 million KRW in external consulting and 2-3 months of internal staff time. Documents are rejected and reworked an average of 2-3 times due to format errors, delaying AI adoption by 6+ months.
Input AI model type, purpose, and data flow to auto-generate a validation document set (URS, FS, DS, IQ/OQ/PQ protocols) compliant with GAMP5/CSV standards. Track MFDS/FDA guideline updates to provide document update alerts, and reduce rejection probability with checklist-based self-audit functionality.
| N Novelty | 1-5 | How uncommon the service is in market context. |
| U Urgency | 1-5 | How urgently users need this problem solved now. |
| M Market | 1-5 | Market size and growth potential from proxy indicators. |
| R Realizability | 1-5 | Buildability for a small team with realistic constraints. |
| V Validation | 1-5 | Validation signal quality from competition and demand data. |
| Tech Complexity | / 40 | Difficulty of core implementation stack. |
| Data Availability | / 25 | Practical availability and cost of required data. |
| MVP Timeline | / 20 | Expected time to ship a usable MVP. |
| API Bonus | / 15 | Bonus for viable public API leverage. |
| Competition | / 20 | Signal quality from competitor landscape. |
| Market Demand | / 20 | Demand proxies from search and mention patterns. |
| Timing | / 20 | Fit with current shifts in tech, behavior, and regulation. |
| Revenue Signals | / 15 | Reference evidence for monetization viability. |
| Pick-Axe Fit | / 15 | How well the concept serves participants in a trend. |
| Solo Buildability | / 10 | Practicality for lean-team implementation. |